{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:29:02Z","timestamp":1790152142926,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3598,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.ymthe.2006.08.001","type":"journal-article","created":{"date-parts":[[2006,9,21]],"date-time":"2006-09-21T11:47:11Z","timestamp":1158839231000},"page":"822-830","source":"Crossref","is-referenced-by-count":51,"title":["Enhanced Efficacy of an AAV Vector Encoding Chimeric, Highly Secreted Acid \u03b1-Glucosidase in Glycogen Storage Disease Type II"],"prefix":"10.1016","volume":"14","author":[{"given":"Baodong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talmage","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"McVie-Wylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-T.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Koeberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2006.08.001_bib1","series-title":"The Metabolic and Molecular Basis for Inherited Disease","first-page":"3389","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.ymthe.2006.08.001_bib2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/j.1460-2075.1988.tb02998.x","article-title":"Primary structure and processing of lysosomal alpha-glucosidase: homology with the intestinal sucrase\u2013isomaltase complex","volume":"7","author":"Hoefsloot","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2006.08.001_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/bj2720485","article-title":"Expression and routing of human lysosomal alpha-glucosidase in transiently transfected mammalian cells","volume":"272","author":"Hoefsloot","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2006.08.001_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/humu.1380020406","article-title":"Two mutations affecting the transport and maturation of lysosomal alpha-glucosidase in an adult case of glycogen storage disease type II","volume":"2","author":"Hermans","year":"1993","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2006.08.001_bib5","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","article-title":"Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular-transport and maturation","volume":"268","author":"Wisselaar","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2006.08.001_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1525-0016(03)00022-4","article-title":"Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus\u2013AAV vector","volume":"7","author":"Sun","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6107(03)00019-1","article-title":"Intracellular sorting and transport of proteins","volume":"83","author":"van Vliet","year":"2003","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ymthe.2006.08.001_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0959-440X(99)00040-8","article-title":"Signal sequence recognition and protein targeting","volume":"9","author":"Stroud","year":"1999","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ymthe.2006.08.001_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.embor.embor736","article-title":"De novo formation, fusion and fission of mammalian COPII-coated endoplasmic reticulum exit sites","volume":"4","author":"Stephens","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2006.08.001_bib10","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1074\/jbc.274.7.4389","article-title":"Cargo can modulate COPII vesicle formation from the endoplasmic reticulum","volume":"274","author":"Aridor","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2006.08.001_bib11","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","article-title":"Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase","volume":"96","author":"Amalfitano","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2006.08.001_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/104303401300042447","article-title":"Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease","volume":"12","author":"Pauly","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/104303401750195917","article-title":"Long-term efficacy after [E1\u2212, polymerase\u2212] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice","volume":"12","author":"Ding","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","article-title":"Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/hum.2005.16.68","article-title":"Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II","volume":"16","author":"Cresawn","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","article-title":"Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II","volume":"12","author":"Franco","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0006-291X(02)00566-1","article-title":"Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression","volume":"294","author":"Barash","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2006.08.001_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1006\/mthe.2002.0594","article-title":"Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice","volume":"5","author":"Elliger","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/90242","article-title":"The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors","volume":"19","author":"Xia","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2006.08.001_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1073\/pnas.93.1.65","article-title":"High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease","volume":"93","author":"Van Hove","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2006.08.001_bib21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.gt.3302314","article-title":"Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model","volume":"11","author":"Xu","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib22","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.96.7.3906","article-title":"Sustained correction of bleeding disorder in hemophilia B mice by gene therapy","volume":"96","author":"Wang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2006.08.001_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mthe.2000.0031","article-title":"Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver","volume":"1","author":"Wang","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib24","first-page":"S23","article-title":"Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A","volume":"8","author":"Ill","year":"1997","journal-title":"Blood Coag. Fibrinol."},{"key":"10.1016\/j.ymthe.2006.08.001_bib25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2006.08.001_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0528.2002.017408.x","article-title":"Local control of the immune response in the liver","volume":"174","author":"Knolle","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2006.08.001_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mthe.2002.0563","article-title":"Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction","volume":"5","author":"Ding","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm901","article-title":"Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion","volume":"9","author":"Haberman","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2006.08.001_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases","volume":"27","author":"Desnick","year":"2004","journal-title":"J. Inherited Metab. Dis."},{"key":"10.1016\/j.ymthe.2006.08.001_bib30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1525-0016(02)90716-1","article-title":"Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme","volume":"6","author":"Raben","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2006.08.001_bib32","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2006.08.001_bib33","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","article-title":"Gene therapy vectors based on adeno-associated virus type 1","volume":"73","author":"Xiao","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2006.08.001_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2003-05-1446","article-title":"Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1","volume":"103","author":"Arruda","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2006.08.001_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","article-title":"Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice","volume":"79","author":"Nakai","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2006.08.001_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gt.3302650","article-title":"Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer","volume":"13","author":"Ghosh","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","article-title":"Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia","volume":"13","author":"Koeberl","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymthe.2006.03.009","article-title":"Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with novel adeno-associated viral vectors","volume":"14","author":"Moscioni","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib39","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1073\/pnas.102175599","article-title":"Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood\u2013brain barrier","volume":"99","author":"Sly","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2006.08.001_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt1073","article-title":"Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart","volume":"23","author":"Wang","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2006.08.001_bib41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/jgm.355","article-title":"Multiple muscles in the AMD quail can be \u201ccross-corrected\u201d of pathologic glycogen accumulation after intravenous injection of an [E1\u00b1, polymerase\u00b1] adenovirus vector encoding human acid-alpha-glucosidase","volume":"5","author":"McVie-Wylie","year":"2003","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2006.08.001_bib42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ymthe.2005.01.012","article-title":"Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymthe.2005.08.006","article-title":"Fully deleted adenovirus persistently expressing GAA accomplishes long-term skeletal muscle glycogen correction in tolerant and nontolerant GSD-II mice","volume":"13","author":"Kiang","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2006.08.001_bib44","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001606014857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001606014857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T13:00:27Z","timestamp":1627822827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001606014857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1525001606014857"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2006.08.001","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}